These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19358084)

  • 21. Mouse models of papillary thyroid carcinoma - short review.
    Rusinek D; Krajewska J; Jarząb M
    Endokrynol Pol; 2016; 67(2):212-23. PubMed ID: 27082155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic causes of the thyroid carcinomas].
    Jindrichová S; Vlcek P; Bendlová B
    Cas Lek Cesk; 2004; 143(10):664-8. PubMed ID: 15584614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raf-1 kinase inhibitory protein expression in thyroid carcinomas.
    Kim HS; Kim GY; Lim SJ; Kim YW
    Endocr Pathol; 2010 Dec; 21(4):253-7. PubMed ID: 20734161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.
    Nikiforova MN; Wald AI; Roy S; Durso MB; Nikiforov YE
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1852-60. PubMed ID: 23979959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
    Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
    Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications.
    Komminoth P
    Virchows Arch; 1997 Jul; 431(1):1-9. PubMed ID: 9247627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer.
    Lopez-Campistrous A; Adewuyi EE; Benesch MGK; Ko YM; Lai R; Thiesen A; Dewald J; Wang P; Chu K; Ghosh S; Williams DC; Vos LJ; Brindley DN; McMullen TPW
    EBioMedicine; 2016 Oct; 12():86-97. PubMed ID: 27682510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of Genetically Engineered Mouse Models of Papillary and Anaplastic Thyroid Cancers: Enabling Translational Biology for Patient Care Improvement.
    Charles RP
    Curr Protoc Pharmacol; 2015 Jun; 69():14.33.1-14.33.14. PubMed ID: 26344211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
    Pallante P; Visone R; Croce CM; Fusco A
    Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
    Oishi N; Kondo T; Ebina A; Sato Y; Akaishi J; Hino R; Yamamoto N; Mochizuki K; Nakazawa T; Yokomichi H; Ito K; Ishikawa Y; Katoh R
    Mod Pathol; 2017 Nov; 30(11):1527-1537. PubMed ID: 28731042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
    Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
    Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial thyroid cancer: a review.
    Nosé V
    Mod Pathol; 2011 Apr; 24 Suppl 2():S19-33. PubMed ID: 21455198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial DNA alterations in thyroid cancer.
    Tong BC; Ha PK; Dhir K; Xing M; Westra WH; Sidransky D; Califano JA
    J Surg Oncol; 2003 Mar; 82(3):170-3. PubMed ID: 12619060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.
    Nikiforova MN; Nikiforov YE
    Expert Rev Mol Diagn; 2008 Jan; 8(1):83-95. PubMed ID: 18088233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
    Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MET receptor tyrosine kinase sequence alterations in differentiated thyroid carcinoma.
    Wasenius VM; Hemmer S; Karjalainen-Lindsberg ML; Nupponen NN; Franssila K; Joensuu H
    Am J Surg Pathol; 2005 Apr; 29(4):544-9. PubMed ID: 15767811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial nonmedullary thyroid carcinoma.
    Malchoff CD; Malchoff DM
    Semin Surg Oncol; 1999; 16(1):16-8. PubMed ID: 9890735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumors.
    Titov SE; Ivanov MK; Karpinskaya EV; Tsivlikova EV; Shevchenko SP; Veryaskina YA; Akhmerova LG; Poloz TL; Klimova OA; Gulyaeva LF; Zhimulev IF; Kolesnikov NN
    BMC Cancer; 2016 Mar; 16():201. PubMed ID: 26960768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
    Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
    Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.